Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
09/2013
09/25/2013CN103328472A Imidazopyridines as respiratory syncytial virus antiviral agents
09/25/2013CN103328471A Method of making azaindazole derivatives
09/25/2013CN103328449A Novel tetrahydroquinoline derivatives
09/25/2013CN103328446A Novel 4-amino-n-hydroxy-benzamides for the treatment of cancer
09/25/2013CN103328442A Azetidine derivatives useful for the treatment of metabolic and inflammatory diseases
09/25/2013CN103320116A Lower alcohol detecting probe, preparation method and application thereof
09/25/2013CN103319488A Inhibitors of bruton's tyrosine kinase
09/25/2013CN103319482A Method for synthesizing 1-hydroxymethyl-2-aza adamantane and derivatives thereof
09/25/2013CN103319481A Extracting process of swainsonine in astragalus strictus
09/25/2013CN103319480A Preparation method of 2, 3, 4, 9-tetrahydro-beta-carboline-1-one
09/25/2013CN103319468A Substituted spirobicyclic compounds, and application method and applications thereof
09/25/2013CN103319464A 病毒聚合酶抑制剂 Viral polymerase inhibitors
09/25/2013CN103319408A Compounds for preventing and treating cardiovascular diseases
09/25/2013CN101696208B Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as CRF antagonists
09/24/2013USRE44510 Multifunctional linker molecules for tuning electronic charge transport through organic-inorganic composite structures and uses thereof
09/24/2013US8541584 3-(1,2,3-triazol-4-yl) pyrrolo [2,3-b] pyridine derivatives
09/24/2013US8541583 Monofunctionalized perylenetetracarboxylic acid bismides
09/24/2013US8541447 3-substituted-2-(arlyalkyl)-1-azabicycloalkanes and methods of use thereof
09/24/2013US8541444 Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
09/24/2013US8541437 Substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles, methods for the production and use thereof
09/24/2013US8541424 Anti-viral compounds
09/24/2013US8541402 Viral polymerase inhibitors
09/24/2013US8541240 Colorimetric and fluorimetric fluoride sensing
09/24/2013CA2745721C Substituted piperidine spiro pyrrolidinone and piperidinones used as h3 modulators
09/24/2013CA2632466C Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
09/24/2013CA2597748C Non steroidal glucocorticoid receptor modulators
09/24/2013CA2568914C Therapeutic agents, and methods of making and using the same
09/24/2013CA2562235C Piperazinylpiperidine derivatives as chemokine receptor antagonists
09/24/2013CA2545425C Azole-based kinase inhibitors
09/24/2013CA2540598C Pyrazolopyridines and analogs thereof
09/24/2013CA2507670C Naphthyridine derivatives and their use as fungicides
09/19/2013WO2013138687A1 Positive allosteric modulators of mglur2
09/19/2013WO2013138436A1 Cyclolic hydrazine derivatives as hiv attachment inhibitors
09/19/2013WO2013138396A1 Dihydropyridopyrimidine and dihydronaphthyridine derivatives as tyrosine kinase inhibitors of especially vegf and pdgf
09/19/2013WO2013137234A1 Transparent electrode, electronic device, and method for producing transparent electrode
09/19/2013WO2013136978A1 Complex compound having imidazo[1,5-a]pyridine derivative as ligand
09/19/2013WO2013136254A1 Heterocyclyl compounds
09/19/2013WO2013136249A1 Heterocyclyl compounds as mek inhibitors
09/19/2013WO2013135671A1 Fungicidal pyrimidine compounds
09/19/2013US20130245355 3-hetaryl-substituted pyrrolo[2,3 b]pyridine derivatives as pdk1 inhibitors
09/19/2013US20130245267 Novel forms of apixaban
09/19/2013US20130245266 Solid forms and process for preparing
09/19/2013US20130245254 Methods of synthesis and purification of heteroaryl compounds
09/19/2013US20130245241 Risperidone Immunoassay
09/19/2013US20130245128 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
09/19/2013US20130245062 Nitrile derivatives and their pharmaceutical use and compositions
09/19/2013US20130245061 Pharmaceutical compositions
09/19/2013US20130245049 Novel Antiviral Compounds
09/19/2013US20130245042 Positive Allosteric Modulators of MGLUR2
09/19/2013US20130245034 Inhibitors Of Histone Deacetylase
09/19/2013US20130245031 Fused heteroaromatic pyrrolidinones
09/19/2013US20130245025 Compounds that modulate intracellular calcium
09/19/2013US20130245012 6-(ethynyl)pyrido[2,3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders
09/19/2013US20130245009 Novel compounds
09/19/2013US20130245006 Novel indolizine derivatives, and preparation and therapeutic use thereof
09/19/2013US20130245002 Triazolopyridine Compounds
09/19/2013US20130245000 Bicyclic gpr119 modulators
09/19/2013US20130244967 Sns-595 and methods of using the same
09/18/2013EP2638042A1 Piperidinone carboxamide azaindane cgrp receptor antagonists
09/18/2013EP2638041A1 Substituted azaindazole compounds
09/18/2013EP2638040A1 RADIOLABELLED mGLuR2 PET LIGANDS
09/18/2013EP2638034A1 Substituted heteroaromatic carboxamide and urea derivatives as vanilloid receptor ligands
09/18/2013EP2638029A1 Triazole derivatives and their use for neurological disorders
09/18/2013EP2638011A1 Novel microbiocides
09/18/2013EP2637704A1 Radiolabelled phenylimidazole-based ligands
09/18/2013EP2637669A2 Heterocyclic compounds and uses thereof
09/18/2013EP2637656A1 Piperidinone carboxamide indane cgrp receptor antagonists
09/18/2013CN103313992A Hdac inhibiting derivatives of camptothecin
09/18/2013CN103313987A Pyrazolopyridines and pyrazolopyridines and their use as tyk2 inhibitors
09/18/2013CN103313986A Novel indolizine derivatives, and preparation and therapeutic use thereof
09/18/2013CN103313985A Crystalline form of pyrimidio[6,1-A]isoquinolin-4-one compound
09/18/2013CN103313979A Novel compound for organic electronic material and organic electroluminescent device using the same
09/18/2013CN103313974A Benzimidazole respiratory syncytial virus inhibitors
09/18/2013CN103313970A Novel bicyclic compound or salt thereof
09/18/2013CN103313968A Nampt and rock inhibitors
09/18/2013CN103313725A Adsorption of immunopotentiators to insoluble metal salts
09/18/2013CN103305210A Phosphorescent host material and preparation method thereof, and organic electroluminescent device
09/18/2013CN103304572A 3-cyanoquinoline compound as well as pharmaceutical composition and application thereof
09/18/2013CN103304565A Vindoline derivative medical application
09/18/2013CN103304564A Beta-carboline derivative containing hydroximic acid as well as preparation method and medical application thereof
09/18/2013CN103304552A Substituted pyridine compound as well as application method and usage thereof
09/18/2013CN103304478A Midbody of one-class synthetic renieramycins type alkaloid and preparation method thereof
09/18/2013CN102344447B Moxifloxacin hydrochloride monohydrate crystal form and preparation method thereof
09/18/2013CN101652364B New indole derivative compounds and pharmaceutical compositions containing the same
09/18/2013CN101641357B 4-substituted azaadamantane derivatives and methods of use thereof
09/18/2013CN101636388B Chemical compounds 637: pyridopyrimidinediones as pde4 inhibitors
09/18/2013CN101535305B 5-hydroxymethyl-oxazolidin-2-one derivatives
09/17/2013US8536332 Modulating signal transduction pathways with substituted pyridol [2,3-b] pyrazines
09/17/2013US8536194 Pyrazolopyridine derivates
09/17/2013US8536193 Inhibitors of AKT activity
09/17/2013US8536164 Fused pyridine compounds as casein kinase inhibitors
09/12/2013WO2013134527A1 Synthesis of polycyclic alkaloids and their use as tgr5 agonists
09/12/2013WO2013134518A1 Sulfamide sodium channel inhibitors
09/12/2013WO2013134252A1 2-amino, 6 - phenyl substituted pyrido [2, 3 - d] pyrimidine derivatives useful as raf kinase inhibitors
09/12/2013WO2013134243A1 2-amino, 6-phenyl substituted pyrido [2, 3 - d] pyrimidine derivatives useful as raf kinase inhibitors
09/12/2013WO2013134079A1 Oxazolidinone compounds and derivatives thereof
09/12/2013WO2013133575A1 Novel compound and organic electroluminescence element including same
09/12/2013WO2013133218A1 Photoelectric conversion element, method for using same, imaging element, optical sensor, and chemical
09/12/2013WO2013131985A1 Immunologically useful arginine salts
09/12/2013WO2013131984A1 Adjuvanted formulations of rabies virus immunogens
1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 646